SEPHSCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。SEPHS遺伝子サイレンサーは、SEPHS CRISPR/Cas9ノックアウトプラスミドとSEPHSDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のSEPHSCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
SEPHS CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
SEPHS1 CRISPR/Cas9 KOプラスミド (h) | sc-408203 | h | Gene Knockout | GFP | 0 | ||
SEPHS1 HDRプラスミド (h) | sc-408203-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
SEPHS1 Double Nickaseプラスミド (h) | sc-408203-NIC | h | Gene Knockout | Puromycin | 0 | ||
SEPHS1 Double Nickaseプラスミド (h2) | sc-408203-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
SEPHS1 CRISPR/Cas9 KOプラスミド (m) | sc-430895 | m | Gene Knockout | GFP | 0 | ||
SEPHS1 HDRプラスミド (m) | sc-430895-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
SEPHS1 Double Nickaseプラスミド (m) | sc-430895-NIC | m | Gene Knockout | Puromycin | 0 | ||
SEPHS1 Double Nickaseプラスミド (m2) | sc-430895-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
SEPHS2 CRISPR/Cas9 KOプラスミド (h) | sc-406316 | h | Gene Knockout | GFP | 0 | ||
SEPHS2 HDRプラスミド (h) | sc-406316-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
SEPHS2 Double Nickaseプラスミド (h) | sc-406316-NIC | h | Gene Knockout | Puromycin | 0 | ||
SEPHS2 Double Nickaseプラスミド (h2) | sc-406316-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
SEPHS2 CRISPR/Cas9 KOプラスミド (m) | sc-423146 | m | Gene Knockout | GFP | 0 | ||
SEPHS2 HDRプラスミド (m) | sc-423146-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
SEPHS2 Double Nickaseプラスミド (m) | sc-423146-NIC | m | Gene Knockout | Puromycin | 0 | ||
SEPHS2 Double Nickaseプラスミド (m2) | sc-423146-NIC-2 | m | Gene Knockout | Puromycin | 0 |
SEPHS CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
SEPHS1 CRISPR Activationプラスミド (h) | sc-408203-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS1 CRISPR Activationプラスミド (h2) | sc-408203-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS1 Lentiviral Activation Particles (h) | sc-408203-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS1 Lentiviral Activation Particles (h2) | sc-408203-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS1 CRISPR Activationプラスミド (m) | sc-430895-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS1 CRISPR Activationプラスミド (m2) | sc-430895-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS1 Lentiviral Activation Particles (m) | sc-430895-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS1 Lentiviral Activation Particles (m2) | sc-430895-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS2 CRISPR Activationプラスミド (h) | sc-406316-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS2 CRISPR Activationプラスミド (h2) | sc-406316-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS2 Lentiviral Activation Particles (h) | sc-406316-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS2 Lentiviral Activation Particles (h2) | sc-406316-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS2 CRISPR Activationプラスミド (m) | sc-423146-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS2 CRISPR Activationプラスミド (m2) | sc-423146-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS2 Lentiviral Activation Particles (m) | sc-423146-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SEPHS2 Lentiviral Activation Particles (m2) | sc-423146-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |